SciELO - Scientific Electronic Library Online

 
vol.76 suppl.2Síndrome isquémico coronario agudo sin elevación del segmento ST: Papel de los inhibidores IIb/IIIa y del intervencionismo coronario percutáneoConsideraciones fisiopatológicas actuales del choque cardiogénico asociado a los síndromes isquémicos coronarios agudos índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Bookmark

  • |

Archivos de cardiología de México

versão impressa ISSN 1405-9940

Resumo

JUAREZ HERRERA, Úrsulo. ST elevation acute coronary syndromes: Pharmaco-mechanic strategy is the universal treatment future?. Arch. Cardiol. Méx. [online]. 2006, vol.76, suppl.2, pp. 252-257. ISSN 1405-9940.

The main objective in the medical treatment of the ST elevation acute myocardial infarction, must have the intention to reperfuse the culprit involved artery. In order to reduce this time, the pharmaco-invasive strategy may offer rapid flow recanalization in the culprit artery and reduce the damage of the myocardium. The new pharmacologic combinations includes half dose of fibrinolytics, alone or in combination with llb/llla inhibitors, this combination may offer advantages of the flow. This concept involves the that PCI (Percutaneous Coronary Interventions), can be done in a subsequent time. The risk of bleeding is increased with this strategy, and some evaluation or bleeding risk must be done in all patients, as in patients with 75 years and older.

Palavras-chave : Acute coronary syndromes; Pharmaco-mechanic strategy; Acute myocardial infarction.

        · resumo em Espanhol     · texto em Espanhol     · pdf em Espanhol